Re: Singh A et al . Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9

[1] on the safety and feasibility of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in testicular cancer patients with postchemotherapy residual mass. [5] reported the overall incidence of chyle leak as 7% in O-RPLND for postchemotherapy residual mass. [...]the safety of RA-RPLND ca...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of urology 2018-01, Vol.34 (1), p.91-92
Main Authors: Temiz, Mustafa Zafer, Cakir, Omer Onur, Kandirali, Engin, Semercioz, Atilla
Format: Article
Language:English
Subjects:
Biopsy
Chemotherapy
Dissection
Letters to Editor
Lymphatic system
Robots
Testicular cancer
Urology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[1] on the safety and feasibility of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in testicular cancer patients with postchemotherapy residual mass. [5] reported the overall incidence of chyle leak as 7% in O-RPLND for postchemotherapy residual mass. [...]the safety of RA-RPLND cannot be superior and we believe that the best inferences on safety and efficacy of RA-RPLND may be derived in a study comparing it with O-RPLND. Robot-assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor.
ISSN:0970-1591
1998-3824
DOI:10.4103/iju.IJU_341_17